Repligen Corporation (RGEN) Documents: SEC Filings, Investor Presentations & Press Releases

Repligen Corporation (RGEN) documents, SEC filings and the IR site together: 125 documents, newest first; latest 2026-09-15. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site
DateTypeDocument
2026-09-158-KForm 8-K, Item 5.02
2026-09-088-KForm 8-K, Item 8.01
2026-07-2910-QForm 10-Q for the quarter ended Jun 30
2026-07-28DeckInvestor presentation · Q2 2026 · Jul 2026
2026-07-28Press releasePress release · Q2 2026 · Jul 2026
2026-07-288-KForm 8-K, Item 2.02 results
2026-07-228-KForm 8-K, Item 2.02 results
2026-07-22TranscriptEarnings call transcript
2026-07-15Press releaseRepligen to Report Second Quarter 2026 Financial Results
2026-06-02DeckRepligen Presentation - William Blair Growth Stock Conference
2026-05-20Press releaseRepligen Announces Publication of the Company’s 2025 Corporate Sustainability Report
2026-05-158-KForm 8-K, Item 5.07
2026-05-0610-QForm 10-Q for the quarter ended Mar 31
2026-05-05DeckRepligen Supplemental Presentation Q1-26 Results · 2026
2026-05-05Press releaseRepligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
2026-05-05Press releaseDownload Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance in PDF form
2026-05-058-KForm 8-K, Item 2.02 results
2026-05-05TranscriptQ1 FY26 earnings call transcript
2026-04-22Press releaseRepligen to Report First Quarter 2026 Financial Results Webcast and Conference Call to Be Held Tuesday, May 5, 2026, at 8:00 a.m. ET
2026-04-02ProxyDefinitive proxy statement
2026-03-26Proxy2025 Annual Report
2026-03-26Annual report2025 Annual Report
2026-03-09DeckInvestor presentation · Mar 2026
2026-02-2610-KAnnual report on Form 10-K, FY25
2026-02-25TranscriptQ4 FY25 earnings call transcript
2026-02-24Press releaseDownload Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance in PD
2026-02-24Press releaseRepligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
2026-02-248-KForm 8-K, Item 2.02 results
2026-02-10Press releaseRepligen to Report Fourth Quarter and Full Year 2025 Financial Results Webcast and Conference Call to Be Held Tuesday, February 24, 2026, at 8:30 a.m. ET
2026-01-13DeckRepligen Presentation - J.P. Morgan 2026 Healthcare Conference
2026-01-068-KForm 8-K, Item 5.02
2025-11-0410-QForm 10-Q for the quarter ended Sep 30
2025-10-288-KForm 8-K, Item 2.02 results
2025-09-028-KForm 8-K, Item 5.02
2025-08-0710-QForm 10-Q for the quarter ended Jun 30
2025-07-298-KForm 8-K, Item 2.02 results
2025-07-29TranscriptQ2 FY25 earnings call transcript
2025-05-158-KForm 8-K, Item 5.03
2025-04-298-KForm 8-K, Item 2.02 results
2025-04-2910-QForm 10-Q for the quarter ended Mar 31

RGEN overview · RGEN earnings · RGEN financials · RGEN KPIs · RGEN ownership · RGEN peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.